LA Private

November 17, 2024

Elders bets on diversification to weather tough times

Elders (ASX:ELD) has announced its financial results for the year ended 30 September 2024. It reported a challenging year marked by fluctuating market conditions and subdued client sentiment, particularly in the first quarter. The company is a leading agribusiness servicing rural and regional Australia, providing agricultural products, services, and advice. Revenue declined by 6% to $3.13bn, while

Elders bets on diversification to weather tough times Read More »

Clinuvel narrows focus to prioritise key programs

Melbourne-based Clinuvel Pharmaceuticals (ASX:CUV) has announced a strategic shift to focus on three core clinical programs while pausing others. This decision aims to accelerate regulatory and commercial milestones for the company, Clinuvel is an Australian biopharmaceutical specialising in treatments for rare genetic, metabolic and systemic disorders. The company is known for its expertise in photomedicine,

Clinuvel narrows focus to prioritise key programs Read More »